GENNEX LABORATORIES
Smallcap | BSE
Sector
Here's the live share price of Gennex Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
13.09₹ 1.25
As on Aug 14, 2026, 04:01 PM IST
Source: Dion Global
Gennex Laboratories Price Performance
Today's LowToday's High
₹9.55₹11.00
₹10.80
52 Weeks' Low52 Weeks' High
₹7.05₹17.25
₹10.80
Open Price
₹9.55
Prev. Close
₹9.55
Volume
45,95,179
Source: Dion Global
Gennex Laboratories Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Gennex Laboratories | 20.67 | 13.33 | 13.56 | -9.55 | -10.89 | 9.17 | 6.65 |
| Sun Pharmaceutical Industries | -1.24 | -0.79 | 3.31 | 13.25 | 17.19 | 19.26 | 19.78 |
| Divi's Laboratories | 3.05 | 18.30 | 22.80 | 38.13 | 38.66 | 31.58 | 11.64 |
| Torrent Pharmaceuticals | -2.26 | -2.63 | 9.78 | 13.61 | 33.63 | 34.92 | 26.78 |
| Cipla | -1.49 | 0.80 | 0.79 | 6.95 | -7.27 | 5.49 | 10.29 |
| Zydus Lifesciences | 2.22 | 0.54 | 15.00 | 25.27 | 15.29 | 21.13 | 16.47 |
| Lupin | -5.30 | -9.49 | -1.01 | 0.65 | 14.04 | 27.37 | 18.23 |
| Dr. Reddy's Laboratories | 2.56 | -3.51 | -7.74 | -5.30 | -4.55 | 1.08 | 5.21 |
| Mankind Pharma | -0.78 | -4.37 | -1.70 | 16.23 | -2.12 | 10.00 | 11.19 |
| Laurus Labs | -2.16 | 16.35 | 37.96 | 79.20 | 111.20 | 67.73 | 21.37 |
| Aurobindo Pharma | -0.18 | 6.77 | 9.83 | 39.93 | 53.11 | 23.90 | 17.57 |
| Biocon | -3.51 | -5.12 | -1.01 | 9.11 | 15.46 | 17.69 | 2.48 |
| Glenmark Pharmaceuticals | 2.32 | 1.50 | -0.01 | 15.19 | 14.48 | 43.16 | 32.67 |
| Alkem Laboratories | -4.11 | -3.56 | -3.23 | -1.48 | 1.00 | 12.50 | 7.76 |
| Abbott India | -2.52 | -1.60 | -1.58 | 2.88 | -18.52 | 4.68 | 7.40 |
| Anthem Biosciences | 5.73 | 18.52 | 8.62 | 29.14 | 7.64 | 6.77 | 4.01 |
| Gland Pharma | 14.32 | 19.53 | 56.86 | 64.31 | 50.59 | 22.87 | -6.37 |
| Ajanta Pharma | 5.65 | 7.93 | 12.96 | 25.24 | 37.36 | 28.71 | 19.40 |
| GlaxoSmithKline Pharmaceuticals | 3.72 | 9.18 | 11.24 | 3.51 | -2.85 | 23.85 | 10.85 |
| Ipca Laboratories | -0.51 | -6.09 | 9.18 | 15.20 | 26.33 | 25.04 | 7.45 |
Source: Dion Global
Over the last one year, Gennex Laboratories has declined 10.89% compared to peers like Sun Pharmaceutical Industries (17.19%), Divi's Laboratories (38.66%), Torrent Pharmaceuticals (33.63%). From a 5 year perspective, Gennex Laboratories has underperformed peers relative to Sun Pharmaceutical Industries (19.78%) and Divi's Laboratories (11.64%).
Gennex Laboratories Financials
Source: Dion Global
Gennex Laboratories Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 8.95 | 8.95 |
| 10 | 8.93 | 8.97 |
| 20 | 9 | 9.12 |
| 50 | 9.81 | 9.6 |
| 100 | 9.94 | 10.15 |
| 200 | 11.55 | 11.05 |
Source: Dion Global
Gennex Laboratories Share Holding Pattern
In the latest quarter, Gennex Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding unchanged at 0.00%, and public shareholding moved up to 76.38% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Gennex Laboratories Corporate Actions
Date Time | Announcement |
|---|---|
| Aug 14, 2026, 10:40 PM IST IST | Gennex Laboratories - Un-Audited Financial Results For The Quarter Ended June 30, 2026 |
| Aug 14, 2026, 10:26 PM IST IST | Gennex Laboratories - Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30, 2026 |
| Jul 29, 2026, 08:06 PM IST IST | Gennex Laboratories - Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Fi |
| Jul 17, 2026, 06:58 PM IST IST | Gennex Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Jun 10, 2026, 10:11 PM IST IST | Gennex Laboratories - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regul |
Source: Dion Global
About Gennex Laboratories
Gennex Laboratories Ltd. is a Public Limited Listed company incorporated on 29/03/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24230TG1990PLC011168 and registration number is 011168. Currently company belongs to the Industry of Pharmaceuticals. Company's Total Operating Revenue is Rs. 119.86 Cr. and Equity Capital is Rs. 24.29 Cr. for the Year ended 31/03/2026.
- IndustryPharmaceuticals
- AddressSy. No.133, Sangareddy Dist. Telangana 502325
- Contact
Source: Dion Global
Management
- Mr. Arihant BaidManaging Director
- Dr. A R R PantuluNon Executive Director
- Mr. Sandeep Kumar DagaNon Executive Director
- Mr. A S Nageswar RaoIndependent Director
- Mr. Dilip Raj SinghviIndependent Director
- Ms. Shilpa BungIndependent Woman Director
FAQs on Gennex Laboratories Share Price
What is the share price of Gennex Laboratories?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Gennex Laboratories is ₹10.80 as on Aug 14, 2026.
What kind of stock is Gennex Laboratories?
The Gennex Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Gennex Laboratories?
The market cap of Gennex Laboratories is ₹262.38 Cr as on Aug 14, 2026.
What are today's High and Low prices of Gennex Laboratories?
Today’s highest and lowest price of Gennex Laboratories are ₹11.00 and ₹9.55.
What are the 52 Week High and 52 Week Low of Gennex Laboratories?
The 52-week high/low is the highest and lowest price at which Gennex Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Gennex Laboratories is ₹17.25 and 52-week low of Gennex Laboratories is ₹7.05 as on Aug 14, 2026.
How has the Gennex Laboratories performed historically in terms of returns?
The Gennex Laboratories has shown returns of 13.09% over the past day, 13.33% for the past month, 13.56% over 3 months, -10.89% over 1 year, 9.17% across 3 years, and 6.65% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Gennex Laboratories?
P/E ratio of and PB ratio of Gennex Laboratories are 10.78 and 1.18 on Aug 14, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global
✕